600201 生物股份
已收盘 03-04 15:00:00
资讯
新帖
简况
生物股份（600201）披露股东股份解除质押公告，2月3日股价上涨0.86%
证券之星 · 02-03
生物股份（600201）披露股东股份解除质押公告，2月3日股价上涨0.86%
【机构调研记录】睿远基金调研生物股份
证券之星 · 02-03
【机构调研记录】睿远基金调研生物股份
2月2日生物股份跌9.81%，国泰中证畜牧养殖ETF基金重仓该股
证券之星 · 02-02
2月2日生物股份跌9.81%，国泰中证畜牧养殖ETF基金重仓该股
每周股票复盘：生物股份（600201）生物控股质押3.10%公司股份
证券之星 · 02-01
每周股票复盘：生物股份（600201）生物控股质押3.10%公司股份
生物股份（600201）股东内蒙古金宇生物控股有限公司质押742万股，占总股本0.67%
证券之星 · 01-27
生物股份（600201）股东内蒙古金宇生物控股有限公司质押742万股，占总股本0.67%
生物股份（600201）披露股东股份质押公告，1月27日股价上涨2.04%
证券之星 · 01-27
生物股份（600201）披露股东股份质押公告，1月27日股价上涨2.04%
海通国际：首次覆盖生物股份给予增持评级，目标价20.7元
证券之星 · 01-20
海通国际：首次覆盖生物股份给予增持评级，目标价20.7元
每周股票复盘：生物股份（600201）大股东首次增持61.46万股
证券之星 · 01-11
每周股票复盘：生物股份（600201）大股东首次增持61.46万股
开源证券：给予生物股份买入评级
证券之星 · 01-08
开源证券：给予生物股份买入评级
1月6日生物股份发布公告，股东增持61.46万股
证券之星 · 01-06
1月6日生物股份发布公告，股东增持61.46万股
1月5日生物股份涨6.57%，国泰中证畜牧养殖ETF基金重仓该股
证券之星 · 01-05
1月5日生物股份涨6.57%，国泰中证畜牧养殖ETF基金重仓该股
生物股份涨6.57%，开源证券二个月前给出“买入”评级
证券之星 · 01-05
生物股份涨6.57%，开源证券二个月前给出“买入”评级
每周股票复盘：生物股份（600201）现240.04万元大宗交易
证券之星 · 01-02
每周股票复盘：生物股份（600201）现240.04万元大宗交易
生物股份（600201）股东内蒙古金宇生物控股有限公司质押840万股，占总股本0.76%
证券之星 · 2025-12-31
生物股份（600201）股东内蒙古金宇生物控股有限公司质押840万股，占总股本0.76%
12月30日生物股份现240.04万元大宗交易
证券之星 · 2025-12-30
12月30日生物股份现240.04万元大宗交易
每周股票复盘：生物股份（600201）大股东拟增持5000万至1亿元
证券之星 · 2025-12-28
每周股票复盘：生物股份（600201）大股东拟增持5000万至1亿元
12月24日生物股份跌7.69%，国泰中证畜牧养殖ETF基金重仓该股
证券之星 · 2025-12-24
12月24日生物股份跌7.69%，国泰中证畜牧养殖ETF基金重仓该股
生物股份(600201.SH)：生物控股拟斥5000万元至1亿元增持公司股份
智通财经网 · 2025-12-23
生物股份(600201.SH)：生物控股拟斥5000万元至1亿元增持公司股份
生物股份涨5.56%，开源证券一个月前给出“买入”评级
证券之星 · 2025-12-23
生物股份涨5.56%，开源证券一个月前给出“买入”评级
12月17日生物股份（600201）龙虎榜数据：机构净卖出9482.71万元，北向资金净卖出5491.7万元
证券之星 · 2025-12-17
12月17日生物股份（600201）龙虎榜数据：机构净卖出9482.71万元，北向资金净卖出5491.7万元
加载更多
公司概况
公司名称：
金宇生物技术股份有限公司
所属行业：
医药制造业
上市日期：
1999-01-15
主营业务：
金宇生物技术股份有限公司的主营业务是兽用生物制品的研发、生产与销售。公司的主要产品是猪用疫苗、反刍动物疫苗、禽用疫苗、宠物类疫苗。
发行价格：
6.83
{"stockData":{"symbol":"600201","market":"SH","secType":"STK","nameCN":"生物股份","latestPrice":14.87,"timestamp":1772607600000,"preClose":14.89,"halted":0,"volume":26762395,"delay":0,"changeRate":-0.0013,"floatShares":1112000000,"shares":1112000000,"eps":0.0907,"marketStatus":"已收盘","change":-0.02,"latestTime":"03-04 15:00:00","open":14.8,"high":15.17,"low":14.73,"amount":401000000,"amplitude":0.0296,"askPrice":14.87,"askSize":1178,"bidPrice":14.86,"bidSize":577,"shortable":0,"etf":0,"ttmEps":0.0907,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1772674200000},"marketStatusCode":5,"adr":0,"adjPreClose":14.89,"symbolType":"stock","openAndCloseTimeList":[[1772587800000,1772595000000],[1772600400000,1772607600000]],"highLimit":16.38,"lowLimit":13.4,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1111747826,"isCdr":false,"pbRate":3.02,"roa":"--","peRate":163.947078,"roe":"3.0%","epsLYR":0.1,"committee":0.041749,"marketValue":16532000000,"turnoverRate":0.0241,"status":1,"floatMarketCap":16532000000},"requestUrl":"/m/hq/s/600201","defaultTab":"news","newsList":[{"id":"2608887293","title":"生物股份（600201）披露股东股份解除质押公告，2月3日股价上涨0.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2608887293","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608887293?lang=zh_cn&edition=full","pubTime":"2026-02-03 22:04","pubTimestamp":1770127491,"startTime":"0","endTime":"0","summary":"截至2026年2月3日收盘，生物股份报收于16.42元，较前一交易日上涨0.86%，最新总市值为182.55亿元。近日，金宇生物技术股份有限公司发布公告称，持股5%以上股东内蒙古金宇生物控股有限公司持有公司股份125,510,800股，占公司总股本的11.29%。本次解除质押后，生物控股累计质押公司股份15,820,000股，占其所持股份的12.60%，占公司总股本的1.42%。生物控股及其一致行动人合计持有公司股份154,647,368股，占公司总股本的13.91%；本次解除质押后累计质押股份占其合计持股的10.23%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020300042778.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0239","BK0188","BK0196","600201","BK0012","BK0046","BK0028","BK0185"],"gpt_icon":0},{"id":"2608204819","title":"【机构调研记录】睿远基金调研生物股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2608204819","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608204819?lang=zh_cn&edition=full","pubTime":"2026-02-03 08:13","pubTimestamp":1770077629,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及2月2日披露的机构调研信息，睿远基金近期对1家上市公司进行了调研，相关名单如下：1）生物股份 调研纪要：公司于2025年7月取得非洲猪瘟亚单位疫苗临床批件，10月启动田间试验，2026年1月23日完成首次攻毒试验，计划2026年4月启动第二轮攻毒试验，6月完成临床数据分析并提交报告，争取早日实现产业化。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020300006756.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0188","BK0028","600201","BK0077","BK0196","BK0239","BK0012","BK0185"],"gpt_icon":0},{"id":"2608085992","title":"2月2日生物股份跌9.81%，国泰中证畜牧养殖ETF基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2608085992","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608085992?lang=zh_cn&edition=full","pubTime":"2026-02-02 16:31","pubTimestamp":1770021115,"startTime":"0","endTime":"0","summary":"证券之星消息，2月2日生物股份跌9.81%，收盘报16.28元，换手率6.66%，成交量74.05万手，成交额12.55亿元。根据2025基金年报公募基金重仓股数据，重仓该股的公募基金共10家，其中持有数量最多的公募基金为国泰基金的国泰中证畜牧养殖ETF。国泰中证畜牧养殖ETF目前规模为59.49亿元，最新净值0.6414，较上一交易日上涨0.25%，近一年上涨16.55%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020200023185.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600201","BK0028","BK0185","516670","BK0077","BK0188","BK0196","BK0012","BK0046","BK0239"],"gpt_icon":0},{"id":"2608077072","title":"每周股票复盘：生物股份（600201）生物控股质押3.10%公司股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2608077072","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608077072?lang=zh_cn&edition=full","pubTime":"2026-02-01 02:09","pubTimestamp":1769882950,"startTime":"0","endTime":"0","summary":"截至2026年1月30日收盘，生物股份报收于18.05元，较上周的17.35元上涨4.03%。本周关注点公司公告汇总：股东内蒙古金宇生物控股有限公司质押7,420,000股，占公司总股本3.10%公司公告汇总生物股份关于股东股份质押的公告金宇生物技术股份有限公司股东内蒙古金宇生物控股有限公司持有公司股份125,474,300股，占公司总股本的11.29%。本次质押后累计质押股份数量为34,420,000股，占其所持股份的27.43%，占公司总股本的3.10%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020100000550.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0185","BK0046","BK0012","BK0239","600201","BK0028","BK0196","BK0188","BK0077"],"gpt_icon":0},{"id":"2606623788","title":"生物股份（600201）股东内蒙古金宇生物控股有限公司质押742万股，占总股本0.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2606623788","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606623788?lang=zh_cn&edition=full","pubTime":"2026-01-27 18:31","pubTimestamp":1769509872,"startTime":"0","endTime":"0","summary":"证券之星消息，生物股份1月27日公开信息显示，股东内蒙古金宇生物控股有限公司向浙商证券股份有限公司合计质押742.0万股，占总股本0.67%。质押详情见下表：截止本公告日，股东内蒙古金宇生物控股有限公司已累计质押股份3442.0万股，占其持股总数的28.0%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012700033089.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0239","BK0028","BK0196","BK0012","600201","BK0046","BK0077","BK0185"],"gpt_icon":0},{"id":"2606020522","title":"生物股份（600201）披露股东股份质押公告，1月27日股价上涨2.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2606020522","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606020522?lang=zh_cn&edition=full","pubTime":"2026-01-27 17:32","pubTimestamp":1769506377,"startTime":"0","endTime":"0","summary":"截至2026年1月27日收盘，生物股份报收于18.5元，较前一交易日上涨2.04%，最新总市值为205.67亿元。该股当日开盘18.26元，最高18.96元，最低17.9元，成交额达11.42亿元，换手率为5.57%。公告显示，公司股东内蒙古金宇生物控股有限公司持有公司股份125,474,300股，占公司总股本的11.29%。本次将其持有的7,420,000股无限售流通股质押给浙商证券股份有限公司，用于融资周转。本次质押后累计质押股份数量为34,420,000股，占其所持股份的27.43%，占公司总股本的3.10%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012700029741.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","600201","BK0185","BK0012","BK0196","BK0046","BK0188","BK0077","BK0239"],"gpt_icon":0},{"id":"2604016157","title":"海通国际：首次覆盖生物股份给予增持评级，目标价20.7元","url":"https://stock-news.laohu8.com/highlight/detail?id=2604016157","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604016157?lang=zh_cn&edition=full","pubTime":"2026-01-20 14:06","pubTimestamp":1768889160,"startTime":"0","endTime":"0","summary":"海通国际证券集团有限公司Yidan Lin近期对生物股份进行研究并发布了研究报告《主业走出谷底，关注非瘟疫苗进展》，首次覆盖生物股份给予增持评级，目标价20.7元。生物股份(600201)本报告导 ...","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.10jqka.com.cn/hks/20260120/c674152985.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun","symbols":["600201"],"gpt_icon":0},{"id":"2602354065","title":"每周股票复盘：生物股份（600201）大股东首次增持61.46万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2602354065","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602354065?lang=zh_cn&edition=full","pubTime":"2026-01-11 03:12","pubTimestamp":1768072330,"startTime":"0","endTime":"0","summary":"截至2026年1月9日收盘，生物股份报收于17.4元，较上周的15.07元上涨15.46%。本周，生物股份1月9日盘中最高价报17.56元，股价触及近一年最高点。股本股东变化股东增减持1月6日，股东内蒙古金宇生物控股有限公司增持生物股份61.46万股，占公司总股本的0.0553%，成交金额约983.22万元。本次增持为2025年12月24日披露的增持计划的首次实施，计划期间为2025年12月24日至2026年12月23日，拟增持金额5000万元至1亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011100000855.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0077","BK0188","BK0239","BK0028","BK0196","600201","BK0185","BK0012"],"gpt_icon":0},{"id":"2601368479","title":"开源证券：给予生物股份买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2601368479","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601368479?lang=zh_cn&edition=full","pubTime":"2026-01-08 18:32","pubTimestamp":1767868379,"startTime":"0","endTime":"0","summary":"开源证券股份有限公司陈雪丽,王高展近期对生物股份进行研究并发布了研究报告《公司深度报告：非瘟亚单位疫苗全球首发在即，创新龙头成长动能强劲》，给予生物股份买入评级。最新盈利预测明细如下：该股最近90天内共有3家机构给出评级，买入评级3家。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010800032121.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["161027","600201"],"gpt_icon":0},{"id":"2601982598","title":"1月6日生物股份发布公告，股东增持61.46万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2601982598","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601982598?lang=zh_cn&edition=full","pubTime":"2026-01-06 17:32","pubTimestamp":1767691951,"startTime":"0","endTime":"0","summary":"证券之星消息，1月6日生物股份发布公告《生物股份:生物股份关于大股东首次增持公司股份暨增持计划实施进展的公告》，其股东内蒙古金宇生物控股有限公司于2026年1月6日合计增持61.46万股，占公司目前总股本的0.0553%，变动期间该股股价上涨0.25%，截止1月6日收盘报16.1元。股东增减持详情见下表：根据生物股份2025年三季报公布的十大股东详情如下：以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010600029153.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0185","BK0188","BK0239","BK0077","600201","BK0028","BK0012","BK0196"],"gpt_icon":0},{"id":"2601100515","title":"1月5日生物股份涨6.57%，国泰中证畜牧养殖ETF基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2601100515","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601100515?lang=zh_cn&edition=full","pubTime":"2026-01-05 15:31","pubTimestamp":1767598294,"startTime":"0","endTime":"0","summary":"证券之星消息，1月5日生物股份涨6.57%，收盘报16.06元，换手率4.98%，成交量55.33万手，成交额8.85亿元。重仓生物股份的公募基金请见下表：该股最近90天内共有3家机构给出评级，买入评级3家。根据2025基金Q3季报公募基金重仓股数据，重仓该股的公募基金共8家，其中持有数量最多的公募基金为国泰基金的国泰中证畜牧养殖ETF。国泰中证畜牧养殖ETF目前规模为60.97亿元，最新净值0.6319，较上一交易日下跌0.75%，近一年上涨11.41%。该公募基金现任基金经理为梁杏。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010500015332.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0196","BK0185","516670","BK0028","600201","BK0012","BK0239","BK0077","BK0188","BK0046"],"gpt_icon":0},{"id":"2601059290","title":"生物股份涨6.57%，开源证券二个月前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2601059290","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601059290?lang=zh_cn&edition=full","pubTime":"2026-01-05 15:31","pubTimestamp":1767598286,"startTime":"0","endTime":"0","summary":"今日生物股份涨6.57%，收盘报16.06元。2025年10月28日，开源证券研究员陈雪丽,王高展发布了对生物股份的研报《公司信息更新报告：业绩修复向上，非瘟疫苗临床实验有序推进》，该研报对生物股份给出“买入”评级。公司业绩修复向上，非瘟疫苗研发加速，新品多点开花持续成长，维持“买入”评级。证券之星数据中心根据近三年发布的研报数据计算，该研报作者对此股的盈利预测准确度为16.03%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010500015328.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600201","161027"],"gpt_icon":0},{"id":"2600036184","title":"每周股票复盘：生物股份（600201）现240.04万元大宗交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2600036184","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600036184?lang=zh_cn&edition=full","pubTime":"2026-01-02 03:04","pubTimestamp":1767294252,"startTime":"0","endTime":"0","summary":"截至2025年12月26日收盘，生物股份报收于15.34元，较上周的14.97元上涨2.47%。本周，生物股份12月23日盘中最高价报16.9元。本周关注点交易信息汇总：生物股份12月30日发生240.04万元大宗交易。本次质押后，生物控股累计质押公司股份数量为27,000,000股，占其持股总数的22.08%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010200000777.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0188","600201","BK0185","BK0046","BK0077","BK0196","BK0028","BK0012"],"gpt_icon":0},{"id":"2595877325","title":"生物股份（600201）股东内蒙古金宇生物控股有限公司质押840万股，占总股本0.76%","url":"https://stock-news.laohu8.com/highlight/detail?id=2595877325","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595877325?lang=zh_cn&edition=full","pubTime":"2025-12-31 18:42","pubTimestamp":1767177731,"startTime":"0","endTime":"0","summary":"证券之星消息，生物股份12月31日公开信息显示，股东内蒙古金宇生物控股有限公司向中国民生银行股份有限公司呼和浩特分行合计质押840.0万股，占总股本0.76%。质押详情见下表：截止本公告日，股东内蒙古金宇生物控股有限公司已累计质押股份2700.0万股，占其持股总数的22.08%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025123100035204.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0188","600201","BK0185","BK0046","BK0077","BK0196","BK0028","BK0012"],"gpt_icon":0},{"id":"2595934267","title":"12月30日生物股份现240.04万元大宗交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2595934267","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595934267?lang=zh_cn&edition=full","pubTime":"2025-12-30 17:42","pubTimestamp":1767087774,"startTime":"0","endTime":"0","summary":"证券之星消息，12月30日生物股份发生大宗交易，交易数据如下：大宗交易成交价格16.23元，相对当日收盘价溢价8.2%，成交14.79万股，成交金额240.04万元，买方营业部为国联民生证券股份有限公司浙江分公司，卖方营业部为财通证券股份有限公司杭州金城路证券营业部。近三个月该股共发生1笔大宗交易，合计成交1479.0手，溢价成交1笔。截至2025年12月30日收盘，生物股份报收于15.0元，下跌2.53%，换手率3.55%，成交量39.43万手，成交额5.96亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025123000029871.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0077","BK0188","BK0239","BK0028","BK0196","600201","BK0185","BK0012"],"gpt_icon":0},{"id":"2594241691","title":"每周股票复盘：生物股份（600201）大股东拟增持5000万至1亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2594241691","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594241691?lang=zh_cn&edition=full","pubTime":"2025-12-28 01:29","pubTimestamp":1766856548,"startTime":"0","endTime":"0","summary":"截至2025年12月26日收盘，生物股份报收于15.34元，较上周的14.97元上涨2.47%。本周，生物股份12月23日盘中最高价报16.9元。生物股份当前最新总市值170.54亿元，在动物保健板块市值排名1/11，在两市A股市值排名1151/5178。生物控股承诺在增持期间及完成后法定期限内不减持所持股份。生物股份关于大股东取得增持专项贷款承诺函的公告大股东内蒙古金宇生物控股有限公司计划在未来12个月内以集中竞价方式增持公司股份，金额不低于5000万元且不超过10000万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122800000165.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0028","BK0196","BK0077","BK0012","BK0188","BK0185","600201","BK0046"],"gpt_icon":0},{"id":"2593422295","title":"12月24日生物股份跌7.69%，国泰中证畜牧养殖ETF基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2593422295","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593422295?lang=zh_cn&edition=full","pubTime":"2025-12-24 15:32","pubTimestamp":1766561537,"startTime":"0","endTime":"0","summary":"证券之星消息，12月24日生物股份跌7.69%，收盘报15.6元，换手率10.29%，成交量114.35万手，成交额17.99亿元。重仓生物股份的公募基金请见下表：该股最近90天内共有3家机构给出评级，买入评级3家。根据2025基金Q3季报公募基金重仓股数据，重仓该股的公募基金共8家，其中持有数量最多的公募基金为国泰基金的国泰中证畜牧养殖ETF。国泰中证畜牧养殖ETF目前规模为60.97亿元，最新净值0.6374，较上一交易日下跌0.52%，近一年上涨11.06%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122400019491.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","600201","BK0196","516670","BK0012","BK0028","BK0185","BK0077","BK0046","BK0188"],"gpt_icon":0},{"id":"2593124496","title":"生物股份(600201.SH)：生物控股拟斥5000万元至1亿元增持公司股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2593124496","media":"智通财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593124496?lang=zh_cn&edition=full","pubTime":"2025-12-23 17:57","pubTimestamp":1766483875,"startTime":"0","endTime":"0","summary":"智通财经APP讯，生物股份(600201.SH)发布公告，基于对公司未来持续稳定发展的信心和长期投资价值的认可，增强投资者信心，公司大股东内蒙古金宇生物控股有限公司(简称“生物控股”)计划自公告披露之日起12个月内，通过上海证券交易所系统以集中竞价方式增持公司股份，增持总金额不低于人民币5000万元，不超过人民币1亿元。更多港股重磅资讯，下载智通财经app更多港股及海外理财资讯，请点击www.zhitongcaijing.com（搜索“智通财经”）；欲加入智通港股投资群，请加智通客服微信(ztcjkf)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1384991.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK0046","BK0188","BK0028","600201","BK0077","BK0196","BK0239","BK0012","BK0185"],"gpt_icon":0},{"id":"2593467875","title":"生物股份涨5.56%，开源证券一个月前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2593467875","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593467875?lang=zh_cn&edition=full","pubTime":"2025-12-23 15:32","pubTimestamp":1766475123,"startTime":"0","endTime":"0","summary":"今日生物股份涨5.56%，收盘报16.9元。2025年10月28日，开源证券研究员陈雪丽,王高展发布了对生物股份的研报《公司信息更新报告：业绩修复向上，非瘟疫苗临床实验有序推进》，该研报对生物股份给出“买入”评级。公司业绩修复向上，非瘟疫苗研发加速，新品多点开花持续成长，维持“买入”评级。证券之星数据中心计算显示，对该股盈利预测较准的分析师团队为中金公司的樊俊豪。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122300019309.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["161027","600201"],"gpt_icon":0},{"id":"2592699517","title":"12月17日生物股份（600201）龙虎榜数据：机构净卖出9482.71万元，北向资金净卖出5491.7万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2592699517","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592699517?lang=zh_cn&edition=full","pubTime":"2025-12-17 17:48","pubTimestamp":1765964899,"startTime":"0","endTime":"0","summary":"证券之星消息，沪深交易所2025年12月17日公布的交易公开信息显示，生物股份因有价格涨跌幅限制的日收盘价格跌幅偏离值达到7%的前五只证券登上龙虎榜。此次是近5个交易日内第1次上榜。截至2025年12月17日收盘，生物股份报收于15.28元，下跌10.01%，跌停，换手率8.44%，成交量93.79万手，成交额14.85亿元。从龙虎榜公布的当日买卖数据来看，机构合计净卖出9482.71万元，北向资金合计净卖出5491.7万元。从龙虎榜数据可以发现和研究机构、游资和散户的资金动向。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121700028189.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","BK0185","BK0046","BK0188","600201","BK0196","BK0239","BK0077","BK0028"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1772655676792,"stockEarnings":[{"period":"1week","weight":-0.0815},{"period":"1month","weight":-0.0866},{"period":"3month","weight":0.1438},{"period":"6month","weight":0.8201},{"period":"1year","weight":1.1414},{"period":"ytd","weight":-0.0133}],"compareEarnings":[{"period":"1week","weight":-0.0156},{"period":"1month","weight":0.0166},{"period":"3month","weight":0.0533},{"period":"6month","weight":0.0708},{"period":"1year","weight":0.2281},{"period":"ytd","weight":0.0286}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"金宇生物技术股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"49033人(较上一季度减少10.70%)","perCapita":"22673股","listingDate":"1999-01-15","address":"内蒙古自治区呼和浩特市土默特左旗经济技术开发区沙尔沁工业园区金宇大街1号","registeredCapital":"111174万元","survey":" 金宇生物技术股份有限公司的主营业务是兽用生物制品的研发、生产与销售。公司的主要产品是猪用疫苗、反刍动物疫苗、禽用疫苗、宠物类疫苗。","listedPrice":6.83},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"生物股份(600201)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供生物股份(600201)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"生物股份,600201,生物股份股票,生物股份股票老虎,生物股份股票老虎国际,生物股份行情,生物股份股票行情,生物股份股价,生物股份股市,生物股份股票价格,生物股份股票交易,生物股份股票购买,生物股份股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"生物股份(600201)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供生物股份(600201)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}